First Quadrant’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

First Quadrant’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,201	Closed	-$226K	–	558
2021 Q4	$226K	Hold	2,201	–	–	0.02%	330
2021 Q3	$193K	Hold	2,201	–	–	0.02%	342
2021 Q2	$197K	Hold	2,201	–	–	0.02%	340
2021 Q1	$167K	Hold	2,201	–	–	0.02%	374
2020 Q4	$150K	Hold	2,201	–	–	0.02%	391
2020 Q3	$117K	Hold	2,201	–	–	0.01%	411
2020 Q2	$128K	Sell	2,201 -7,374	-77%	-$396K	0.02%	493
2020 Q1	$377K	Buy	+9,575	New	+$560K	0.05%	311
2019 Q2	–	Sell	-12,151	Closed	-$629K	–	761
2019 Q1	$629K	Buy	12,151 +9	+0.1%	+$436	0.05%	326
2018 Q4	$478K	Buy	12,142 +10,318	+566%	+$479K	0.04%	364
2018 Q3	$94K	Buy	+1,824	New	+$89.3K	﹤0.01%	717
2017 Q4	–	Sell	-80,204	Closed	-$4.2M	–	988
2017 Q3	$4.2M	Buy	80,204 +79,818	+20,678%	+$4.45M	0.08%	266
2017 Q2	$23K	Buy	+386	New	+$20.1K	﹤0.01%	862

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

First Quadrant's SYNH Position: Q1 2022 in Review

First Quadrant sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 2,201 shares — an estimated $226K sold.

First Quadrant first reported a position in SYNH in Q2 2017 and held it in 13 quarters. The position peaked at $4.2M in Q3 2017. 365 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

First Quadrant reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
First Quadrant sold 2,201 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $226K.
First Quadrant first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 13 quarters.
First Quadrant's Syneos Health, Inc. Class A Common Stock position peaked at $4.2M in Q3 2017.
365 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.